Change Language
Call Us08045804708
Casirivimab  Imdevimab

Casirivimab Imdevimab

Product Details:


Product Description

It contains two monoclonal antibodies used together for the emergency treatment of mild to moderate covid-19 in adults and children aged 12 years and above and over 40 kg in weight. It is most effective if taken after an early laboratory diagnosis (within 7 to 10 days).

The most common side effects of this monoclonal antibody therapy are injection site reactions, fever, flushing, shortness of breath, chest tightness, nausea, and vomiting. If you experience any of these side effects, let your doctor know immediately.

Storage: Store in a refrigerator (2 - 8 Deg c). Do not freeze.

Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Pharmaceutical Injection' category

We are mainly deals in Foreign Countries.
Back to top